Work Area: Litigation

Latest content

PTAB petitioners will love this – to patent owners’ detriment

Saturday Opinion: The US Patent and Trademark Office’s decision to enable director reviews of PTAB institution decisions is just what Big Tech has been seeking for years

29 July 2023

US Chamber of Commerce on proposed noncompete ban: “We do not want to see FTC acting like a legislator”

Senior Vice President Sean Heather tells IAM that the body is prepared to sue over the FTC’s lack of lawmaking competence

28 July 2023

IAM’s top takeaways from IPBC Global 2023

Litigation funding, looking beyond patents and driving business in new markets – our editorial team reflects on the key messages from the world’s leading IP conference

27 July 2023

Samsung, LG, Bose among targets of new US patent assertions by familiar figure

OnePlus and Pioneer were also sued by the Canadian IP monetiser behind 2022’s most prolific NPE, now asserting a new portfolio under a new name

26 July 2023

Nokia wins UK willingness decision, while Oppo terminates French distribution

Chinese handset maker to concede to UK-set FRAND rate or be injuncted in the country

26 July 2023

Here’s how Huawei cut its US patent risk and litigation defence costs

“We have no choice but to take a balanced approach to patent licensing,” Huawei US Chief IP Counsel Steven Geiszler tells IAM in an exclusive interview

25 July 2023

Huawei’s US patent litigation sheds light on its licensing approach

The Chinese telecoms giant is actively licensing its SEP portfolios in the US but will not rush to court, as shown by its scant assertion record, shows Docket Navigator

24 July 2023

Ocado gets £200 million in ‘robot wars’ settlement after turning the tables on AutoStore

Much-watched global patent dispute ends with agreement highly favourable to UK-based robotic warehouse business

24 July 2023

IAM and WTR join forces for Latin America IP strategy event

Corporate IP executives, deal makers, brand leaders, policy experts and legal advisers will convene in São Paulo to share best practices and insights

22 July 2023

Genentech sues Biogen as new wave of biosimilars disputes grows

Case concerns 20 asserted patents but this figure may be whittled down during litigation process

21 July 2023

Unlock unlimited access to all IAM content